Skip to main content

Promotion of hair growth by a conditioned medium from human umbilical cord mesenchymal stem cells cultivated in a 3D scaffold of gelatin sponge



This study aims to investigate the effects of a conditioned medium (CM) from human umbilical cord mesenchymal stem cells (HuMSCs) cultivated in gelatin sponge (GS-HuMSCs-CM) on hair growth in a mouse model.


CM was collected from the HuMSCs cultivated in a monolayer or in a gelatin sponge. Vascular endothelial growth factor (VEGF), insulin-like growth factor-1 (IGF-1), keratinocyte growth factor (KGF), and hepatocyte growth factor (HGF) levels in CMs were measured by enzyme-linked immunosorbent assays (ELISAs). A hair loss model by a C57 BL/6J mouse was prepared. The effects of GS-HuMSCs-CM and HuMSCs on hair regrowth in mice were investigated by intradermal injection in the depilated back skin with normal saline (NS) as the control. The time for hair regrowth and full covering in depilated areas was observed, and the hair growth was evaluated histologically and by grossly measuring hair length and diameter.


Compared with monolayer cultured cells, the three-dimensional (3D) culture of HuMSCs in gelatin sponge drastically increased VEGF, IGF-1, KGF, and HGF production. GS-HuMSCs-CM and HuMSCs injection both promoted hair regeneration in mice, while GS-HuMSCs-CM presented more enhanced effects in hair length, hair diameter, and growth rate. GS-HuMSCs-CM significantly promoted angiogenesis in injected skin areas, which might also contribute to faster hair regrowth.


GS-HuMSCs-CM exerted significant effects on inducing hair growth and promoted skin angiogenesis in C57BL/6J mice.


Hair loss is typically divided into non-scar alopecia and scar alopecia. Androgenic alopecia (AGA) is the major type of non-scar alopecia, affecting 60–70% of the population [1]. AGA not only affects patients’ appearance but also exerts heavy physical and mental pressure, severely affecting their quality of life and social activity [2]. The hair follicle is a micro-organ that contains epithelial and mesenchymal compartments and is a highly sensitive skin appendage and self-regenerating system, which undergoes life-long cycles, namely rapid growth stage (anagen), regression stage (catagen), and resting stage (telogen) [3]. Alopecia is closely related to the abnormal hair growth cycle, including the shorter duration of the anagen phase, a reduced percentage of anagen phase hair follicles, and the prolongation of the telogen stage [4]. Therefore, the treatment strategies for hair loss include prolonging anagen and reducing the number of hair follicles in telogen. Currently, the treatments for hair loss include drugs such as finasteride and minoxidil, hair transplant, low-level laser therapy, cosmetic camouflages, platelet-rich plasma (PRP), and extracts from cultured MSCs, which presented reliable anti-AGA effects with fewer side effects and with sustainable production and supply [5, 6].

Stem cells, which possess the capacity for self-renewal and multipotent differentiation, have gained significant research attention as a potentially effective therapy. Mesenchymal stem cells (MSCs) are a popular cell source for stem cell-based therapies and are found in bone marrow, umbilical cord blood, Wharton’s jelly, placenta, adipose tissue, and dental pulp tissue [7]. However, MSC therapy possess potential risks including infectious disease, immunological rejection, acute immunogenic responses, and long-term chronic immunogenicity or tumorigenicity [8]. MSCs produce a variety of growth factors that enter the microenvironment and activate neighboring cells [9], and promote tissue repair and regeneration largely through paracrine action by the growth factors [10]. The conditioned medium, which contains the secreted growth factors from cultivated MSCs (MSCs-CM), is considered a potentially effective approach for regenerative medicine [11].

Human umbilical cord mesenchymal stem cells (HuMSCs) are isolated from Wharton’s jelly. They have broad clinical application prospects in brain, bone, myocardium, lung, pancreas, liver, and autoimmune diseases [12,13,14,15,16,17,18]. Compared with other stem cell sources, HuMSCs exhibit a high proliferation rate; short reproduction time; low immunogenicity; high safety; easier isolation, culture, and manipulation; and less genetic mutation during passaging [19]. Collecting HuMSCs is painless and non-invasive; thus, the procedure is robust against ethical controversy [20]. Currently, MSCs, such as adipose-derived stromal cells (ADSCs), bone marrow MSCs (BM-MSCs), and dental-derived mesenchymal stem cells have been analyzed in hair-loss treatment [21,22,23]. Moreover, the cell-free MSCs-CM could promote hair regeneration [24]. HuMSCs were found to secrete higher concentrations of growth factors and cytokines compared with other MSCs sources [25, 26]. Growth factors and cytokines in HuMSCs-CM potentially modulate the micro-environment and may thereby effect significant roles in hair growth.

The growth factors and cytokines in CM are essential for therapeutic strategies, and several approaches have been developed to increase the levels of growth factors and cytokines secreted by MSCs. Hypoxia benefits the growth factor secretion of ADSCs and promotes hair growth [27]. A low dose of ultraviolet radiation B (UVB) significantly stimulated the paracrine effects of ADSCs and increased the secretion of ADSCs growth factors, thus inducing hair follicle formation and promoting hair regeneration in mice [28]. In our previous study, HuMSCs were seeded in a 3D structure of platelet-poor plasma (PPP) gel and manifested an increased concentration of growth factors and cytokines in CM [26]. We also described an approach for seeding HuMSCs in a poly-L-lysine (PLL)-coated gelatin sponge and demonstrated that the proposed culture consistently secreted significantly higher levels of growth factor compared to monolayer cultures [29].

We propose that the CM collected from HuMSCs cultivated in a gelatin sponge (GS-HuMSCs-CM) might be an effective strategy for promoting hair growth. To verify this hypothesis, we prepared CM from the 3D cultured HuMSCs and investigated the effects on hair growth in C57BL/6 mice in vivo, with HuMSCs and normal saline as contrasts.

Materials and methods

Isolation and culture of human umbilical cord mesenchymal stem cells

The study was approved by the Ethics Committee of Shantou University Medical College (SUMC, Shantou, China). Umbilical cords were obtained from healthy pregnant women (excluding those with HIV, hepatitis, and syphilis) at term (38–40 weeks) through cesarean section in the Obstetrics and Gynaecology Department of the Second Affiliated Hospital of SUMC, after obtaining written informed consent. HuMSCs were prepared as previously described [26]. The umbilical cord was cut into 2–3 cm pieces with a sterile scalpel and cleaned with sterile phosphate-buffered saline (PBS). After removing the umbilical arteries, veins, and umbilical cord adventitia from the umbilical cord, Wharton’s jelly was obtained. Wharton's Jelly tissues were cut into 2 mm2 pieces and attached to the bottom of 100 mm cell culture dishes (JET BIOFIL, China). The culture dishes were subsequently inverted at 5% CO2 and 37 ℃ for 15–30 min until tissue blocks adhered to the bottom of the dishes. Dulbecco’s High Glucose Modified Eagle’s Medium (DMEM, Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 2% fetal bovine serum (Gibco, USA), 1% penicillin–streptomycin (Beyotime, Shanghai, China), transferrin (Sigma-Aldrich Co., USA), basic fibroblast growth factor (bFGF, Zhuhai Essex Pharmaceutical Co., LTD., China), insulin (Sigma-Aldrich, USA), and selenium acid (Aldrich, Sigma-Aldrich, Co., USA), as previously described [30], was added, and the tissue blocks were incubated in a humidified CO2 incubator at 37 °C. The medium was replaced after HuMSCs grew out of the tissues after 5–7 days.

Conditioned medium from human umbilical cord mesenchymal stem cells seeded in gelatin sponge

The conditioned medium of HuMSCs used was the 3rd-5th passage. GS-HuMSCs-CM was prepared as previously described [29]. Briefly, gelatin sponges (Xiang’en, Jiangxi Medical Technology Development Co., LTD., China) were cut into 20 mm × 20 mm × 10 mm pieces in a sterile environment. Subsequently, gelatin sponges were coated with PLL (Beyotime, China). The third-generation HuMSCs were seeded in PLL-coated gelatin sponges (GS-HuMSCs). Each gelatin sponge piece was seeded with 1.5 mL HuMSCs suspension (3 × 106 cells /mL) and incubated in a 6-well plate at 5% CO2, 37 ℃ for 30 min. GS-HuMSCs were cultured in a 6 mL culture medium with 1 μL/mL ascorbic acid at 37 °C with 5% CO2 for 48 h. Conditioned medium was harvested from three groups: a group of HuMSCs at 100% confluency, a group of monolayer culture HuMSCs (Day 3 after confluency), and a group of GS-HuMSCs-CM (Day 3 after seeded in gelatin sponge). One day before the conditioned medium collection, the culture medium was changed to be serum-free. The CM was collected and centrifuged at 3000 rpm for 10 min to remove floating cells and cell debris, and then allotted and preserved at −80 °C prior to ELISA analysis. The cells were harvested and counted after CM collection.

Evaluation of growth factor levels (ELISA assay)

The CM of HuMSCs at 100% confluence, HuMSCs-CM (Day 3), and GS-HuMSCs-CM (Day 3) were collected, and the levels of VEGF, IGF-1, KGF, and HGF in CM were quantified by ELISA kits (R&D Systems, USA) according to the manufacturer’s instructions. All data were compiled from a minimum of three replicate experiments, with each performed in duplicate, and growth factor levels were calculated from four-parameter logistic curves. Finally, the growth factor concentration was adjusted to be ng (or pg) /ml/million cells.

Animals and ethical approval

6–7 week-old wild-type male C57BL/6J mice, weighing 20–22 g, were purchased from the Animal Center of Shantou University Medical College (Shantou, China). All protocols were approved by the Ethics Committee of the SUMC, and all animal experiments were approved by the Institutional Animal Care and Use Committee of the Shantou University Medical College and conducted according to the guidelines of the National Health and Medical Research Council (China).

Animal experiments

The mice were maintained in a 12 h light–dark cycle under a room temperature of 26 ± 2 °C. The C57BL/6J male mice were kept for one week before the experiments. The mice were anesthetized by inhaling isoflurane. The dorsal hair (2 cm × 4 cm) was shaved with an electric clipper and completely removed using hair remover cream (Reckitt Benckiser France, CEDEX, France). The mice were randomly assigned to three groups (n = 9 each): the control group (normal saline), HuMSCs group, and GS-HuMSCs-CM group. Mice in the control group were administered normal saline, mice in the HuMSCs group were administered 1 × 107 fresh HuMSCs suspended in normal saline, and mice in the GS-HuMSCs-CM group were administered GS-HuMSCs-CM, 16 points for intradermal injection, and 100 uL/point, once per three days for three times. Intradermal injections were administered with a 31-gauge needle at a depth of approximately 1 mm. (Fig. 1).

Fig. 1
figure 1

Schematic diagram of the preparation of HuMSCs, GS-HuMSCs-CM, experimental model and treatment process. Saline (control), HuMSCs, GS-HuMSCs-CM, respectively, were injected subcutaneously in the dorsal skin of each mouse once per 3 days for three times. HuMSCs Human umbilical cord mesenchymal stem cells, GS gelatin sponge, CM conditioned medium

Hair growth observation

Skin darkening and hair growth were monitored. The hair growth score was evaluated as described by Vegesna et al. [31]. Briefly, a score of 0 indicated that the dorsal skin is still pink compared with the start time of the hair growth induction, and a score of 10 indicated full hair regrowth in the entire depilated area. The morphological changes of each group injected with normal saline (control), HuMSCs, or GS-HuMSCs-CM at day 0, day 7, day 10, day 14, and day 21 were captured by a digital camera (EOS 6D, Canon, Japan). The hairs of three areas (1 cm2) on the back of mice on day 14 and day 21 were obtained and weighed on a Sartorius BSA224S-CW 1/10,000 analytical balance (Sartorius, Beijing, China). On day 14 and day 21, thirty hairs were randomly selected from the same area of each mouse, the longest and the shortest hairs were excluded, and ten hairs were retained for length and thickness measurement using a micrometer (SangNond, Shenzhen, China) with a 0.01 mm at 10 × magnification accuracy under an inverted microscope (Olympus CKX31).

Hematoxylin and eosin (H&E) staining

On day 7, day 14, and day 21 after treatment, three mice were randomly selected from each treatment group and sacrificed. Skin samples were harvested, fixed, embedded in paraffin, and sectioned at 4 µm. Sections were rehydrated, dewaxed, and stained with hematoxylin–eosin (H&E) according to respective protocols. The images were captured and viewed using a microscope at 40 × and 400 × magnification. The hair-growth conditions and the hair follicle’s growth phase were observed under the microscope. The hair follicles in six randomly selected fields of view (200 ×) were counted under a microscope, and the average was calculated.

Statistical analysis

Each experiment was repeated at least three times. The data were statistically analyzed using one-way ANOVA and the least-squares difference test for the comparison among groups using SPSS ver. 25.0 (SPSS Inc., Chicago, IL, USA) for Windows statistical package. Significance was defined as P < 0.05. All data were reported as a mean ± standard error of the mean (SEM) of at least 3 separate experiments.


Morphology of umbilical cord mesenchymal stem cells

Around the edges of the block tissues, cells started growing, which was observed under the inverted microscope (Olympus CKX31) (Fig. 2a). Cells were passaged till their proliferation attained 80–90% confluency (Fig. 2b).

Fig. 2
figure 2

Morphology of primary and passage cultured HuMSCs. a Primary cultured HuMSCs at Day 7. The HuMSCs (red triangle) migrated out from adherent tissue Wharton's jelly tissues (white triangle). HuMSCs showed fibroblast-like morphology. b The HuMSCs were inoculated into the petri dishes at a concentration of 1.5 × 105. c HuMSCs reached 80–90% confluence. HuMSCs human umbilical cord mesenchymal stem cells

Growth factor levels increased in GS-HuMSCs-CM

We investigated the growth factors in CMs. The levels of VEGF, KGF, HGF, and IGF-1were all markedly higher in the GS-HuMSCs-CM group than in the monolayer culture HuMSCs-CM (Day 3 after confluency) and HuMSCs100% confluence groups (Fig. 3).

Fig. 3
figure 3

Growth factor assessment of HuMSCs100% confluence group, monolayer group, and GS-HuMSCs-CM groups. The conditional medium of HuMSCs100% confluence was collected, and the conditional medium of monolayer group and GS-HuMSCs-CM group was collected on the third day. AD showed the secretion trend of VEGF, IGF-1, KGF and HGF. (*p > 0.05, **p < 0.01, ***p < 0.001). Group 1: 100% confluence group; Group 2: monolayer group (day 3); Group 3: GS-HuMSCs-CM group

Hair-growth-promoting effects of GS-HuMSCs-CM, HuMSCs, and saline in C57BL/6J mice

It is generally accepted that the dorsal hair of the C57BL/6J mouse exhibits a time-synchronized hair-growth cycle. The depilated skin of mice was pink in telogen. After the intradermal injection of saline (control), HuMSCs, and GS-HuMSCs-CM on the back of mice three times, we observed the changes in skin color and hair growth.

Mice injected with GS-HuMSCs-CM exhibited more rapid hair growth than mice injected with HuMSCs and saline (Fig. 4a, b). On day 7 after injection, mice in the GS-HuMSCs-CM and HuMSCs treatment groups manifested marked dark spots on depilated skin, while there were no marked spots in the control-group mice. Hair shafts of the GS-HuMSCs-CM and HuMSCs treatment groups were visible on day 10 after injection. Specifically, the skin of the GS-HuMSCs-CM group was darker than that of the control group on day 10 after depilation. More hair shafts were observed in GS-HuMSCs-CM groups than in HuMSCs and the control group (Fig. 4). On day 14, 95%–100% of hair coverage was observed in the GS-HuMSCs-CM group, 85%–90% of hair coverage in the HuMSCs group, and 40%–70% of hair coverage in the control group. On day 21, the hair was overgrown in the depilated area on the back of the GS-HuMSCs-CM group and HuMSCs group, but not in the control group.

Hair was collected from injected areas on day 14 and day 21 of each group. On day 14 and day 21 after the injection, the hair weight in the GS-HuMSCs-CM group (2.55 ± 0.13 mg and 5.17 ± 0.04 mg, respectively, n = 6) was significantly heavier than that in the HuMSCs group (1.49 ± 0.03 mg and 3.42 ± 0.03 mg, respectively, n = 6) and control group (0.64 ± 0.01 mg and 3.35 ± 0.02 mg, **P < 0.01; n = 6). On day 14, the HuMSCs group (1.49 ± 0.03 mg, respectively, n = 6) was heavier than the control group (0.64 ± 0.01 mg, **P < 0.01, n = 6). However, on day 21, there was no statistical difference between the HuMSCs group and control group (*P > 0.05) (Fig. 5). On day 14 and day 21 after the last injection, hair length measurements were performed. On day 14 (Fig. 6a) and day 21 (Fig. 6b) after the last injection, the hair length of mice in the GS-HuMSCs-CM group (4.35 ± 0.23 and 7.67 ± 0.16 mm, respectively, n = 10) was significantly longer than that in the HuMSCs group (3.81 ± 0.17 and 6.55 ± 0.14 mm, **P < 0.01, respectively, n = 10) and control group (3.47 ± 0.15 and 6.33 ± 0.16 mm, ***P < 0.001, respectively, n = 10). The hair length of mice in the HuMSCs group (3.81 ± 0.17 and 6.55 ± 0.14 mm, respectively, n = 10) was longer than that of mice in the control group (3.47 ± 0.15 and 6.33 ± 0.16 mm, **P < 0.01, *P < 0.05, n = 10) (Fig. 6). On day 14 after the last injection, the diameters of 10 hairs were measured under the microscope with a microscale (Fig. 7a). The hair diameter of mice in the GS-HuMSCs-CM group (0.056 ± 0.005 mm, n = 10) was significantly thicker than that of mice in the HuMSCs group (0.041 ± 0.006 mm, *P < 0.01, n = 10) and control group (0.030 ± 0.008 mm, *P < 0.01, n = 10). The hair diameter of mice in the HuMSCs group (0.041 ± 0.006 mm, *P < 0.01, respectively, n = 10) was thicker compared with the control group (0.030 ± 0.008 mm, *P < 0.01, respectively, n = 10) (Fig. 7b).

Fig. 4
figure 4

Hair growth effect of GS-HuMSCs-CM in hair loss induced C57BL/6 J mice. The hairs were depilated from the backs of C57BL/6 J, and the hair growth rate was observed 3 times per week for 21 days. The backs of mice were injected with GS-HuMScs-CM, HuMSCs, and saline (control), respectively, once per 3 days for 3 times. The gross view was observed by photographs (a), and hair growth scoring was measured (b). From day 5 to day 15, mice in the GS-HuMSCs-CM injection group showed significantly increased hair growth compared with the HuMSCs group (**P < 0.05, n = 9). The GS-HuMSCs-CM group and the HuMSCs group showed significantly increased hair growth compared with the control group (#P < 0.01, n = 9; P < 0.05, n = 9)

Fig. 5
figure 5

Hair weight at Day 14and Day 21after injection of GS-HuMSCs-CM, HuMSCs, and saline. The hair weight of mice in GS-HuMSCs-CM group and HuMSCs group were significantly weighter compared with the control group (**p < 0.01, *p < 0.05, n = 6). The HuMSCs injection group also showed significantly weight hair regeneration compared with the control group (p < 0.05, n = 6)

Fig. 6
figure 6

Hair growth effect of GS-HuMSCs-CM in hair loss induced C57BL/6 J mice. Hair length at Day 14, Day 21 after subcutaneous injection of saline (control), HuMSCs and GS-HuMSCs-CM. Hair length was measured for Day 14 (a), Day 21 (b). Mice in the GS-HuMSCs-CM injection group showed significantly increased hair length compared with the HuMSCs injection group (**p < 0.01, n = 10) and negative control group (***p < 0.001, n = 10). The HuMSCs injection group also showed significantly increased hair length compared with the control group (**p < 0.01, *p < 0.05, n = 10). The data shown represent one of each group, and experiments were performed three times

Fig. 7
figure 7

Hair diameter at Day14 after injection of GS-HuMSCs-CM, HuMSCs, and saline. The diameter of the hair in the GS-HuMSCs-CM group, HuMSCs group and the control group were measured by microscopically side microscale and they were compared (a). The hair diameter of mice in GS-HuMSCs-CM group and HuMSCs group were significantly thicker compared with the control group (*p < 0.01, n = 10). The HuMSCs injection group also showed significantly weight hair regeneration compared with the control group (p < 0.01, n = 10) (b)

GS-HuMSCs-CM increased neo-angiogenesis in C57BL/6 Mice

Mice were sacrificed, and the back skin was turned over on day 7, day 14, and day 21 after the last injection. Compared with the control group, blood vessels increased in number and diameter in the GS-HuMSCs-CM group and HuMSCs group on day 7. However, no apparent changes were noted in the control. On day 14 and day 21, the GS-HuMSCs-CM group and HuMSCs group manifested higher blood vessel density and thicker and more branching vessels in the dorsal skin. However, the dorsal vessels of the control group were smaller in diameter, with lower density and sparser branches. The number of neoangiogenesis in the GS-HuMSCs-CM group was higher than that in the HuMSCs group on days 7, 14, and 21 (Fig. 8).

Fig. 8
figure 8

Stimulatory effect of GS-HuMSCs-CM on angiogenesis. The vascularization of the hair regeneration site was analyzed Day 7, Day 14 and Day 21 after injection. The skin of the hair regeneration site in the GS-HuMSCs-CM group and the HuMSCs group showed mature vascular branches. The control group had smaller vessels with fewer branches. Mature angiogenesis was significantly enhanced in the GS-HuMSCs-CM group

Histological findings of dorsal hair follicle changes in mice

The growth cycle of hair follicles was histologically observed according to a protocol described by Muller et al. [32]. Skin tissue was harvested and processed for histological investigation.

On day 7, hairs in the GS-HuMSCs-CM group were in the anagen phase (Anagen II), and in Anagen I in the HuMSCs group, while the control group hairs were in the telogen phase. Meanwhile, in the GS-HuMSCs-CM group, the dermis became thicker with larger hair follicles deeper into the subcutaneous tissue than the HuMSCs group, and more melanin was around the dermal papilla. However, the control group’s dermis was thin with hair follicles still residing in the dermal layer. (Fig. 9A (a)—C (c)). On day 14, hairs in the GS-HuMSCs-CM group were in Anagen V, with increased hair number and larger dermal papilla in the hair follicles. Melanin significantly increased, and the inner root sheath (IRS) grew from the dermal papilla and into the dermis. In the HuMSCs group, hairs were in Anagen IIIc, with larger dermal papilla, and melanin increased. The control group entered Anagen IIIa, with a few hair follicles growing, and melanin surrounded the dermal papilla (Fig. 9D (d)—F (f)). On day 21, in the GS-HuMSCs-CM group, the dermal papilla became smaller, the melanin gradually decreased, the hair follicle bulb became narrower, and the hair follicles began to enter early catagen (Catagen II). In the HuMSCs group, the density of hair follicles and melanin decreased, and the hair follicles entered the anaphase stage of catagen (Catagen VI). In the control group, the dermal papilla was separated from the hair shaft, the melanin decreased, and the hair follicles were in catagen (Catagen VIII) (Fig. 9G (g)—I (i)).

Fig. 9
figure 9

GS-HuMSCs-CM promotes the conversion from telogen to anagen in C57BL/6 J mice. Histological evaluation of the control group, HuMSCs group and GS-HuMSCs-CM group (Day 7, Day 14 and Day 21). AI is viewed under 40 × microscope field. a–i is viewed under 400 × microscope field. A (a)–C (c) shows the changes of hair follicles at Day 7. D (d)–F (f) shows the changes of hair follicles at Day 14. G (g)–I (i) showed the change of hair follicles on Day 21. Day 7, the GS-HuMSCs-CM group had entered the Anagen IIIc (c), and the HuMSCs group also entered the Anagen II (b), while the negative group was still in the telogen phase (a). Day 14, the GS-HuMSCs-CM group was still in the Anagen V (f), the HuMSCs group was also in the anagen IIIc (e), and the control group entered the Anagen IIIa (d). Day 21, the GS-HuMSCs-CM group was in the early catagen phase (i), while both the HuMSCs group and the control group entered the telogen phase (h–i)

On day 7, day 14, and day 21, dorsal skin tissues were harvested and quantified for hair follicle density under a microscope (Fig. 10A). Depilated skin treated with GS-HuMSCs-CM and HuMSCs exhibited higher hair follicle density and more terminal hairs than the tissue treated with saline, and the hair-promoting effect of GS-HuMSCs-CM was stronger than that of HuMSCs (*P < 0.01) (Fig. 10B).

Fig. 10
figure 10

Increased hair growth and hair follicle density in mice by GS-HuMSCs-CM. A. Representative hematoxylin–eosin (H&E) images of dorsal skin sections for determination of hair follicle (HF) number. B. The number of hair follicles in 6 areas was randomly observed and counted under 200 × microscope field. Data are represented as the mean ± SD (n = 6, *p < 0.01)


We investigated the ability of HuMSCs secretome to promote hair growth. In an animal model, HuMSCs cultured in a gelatin sponge secreted growth factors and cytokines of high levels into CM, which promoted hair regeneration. GS-HuMSCs-CM exerted hair-growth promoting effects via anagen induction, thereby promoting hair follicle growth and neo-angiogenesis.

The C57BL/6 mouse is the best animal model for hair-cycle analysis. Under favorable feeding conditions, all hair follicles of C57BL/6 mice entered telogen at 6–8 weeks after birth, and in the physiological state, hair follicles no longer spontaneously enter anagen [33]. After traumatic stimulation such as manual depilation or hair pluck, the hair follicles can be induced to enter anagen and then enter telogen after catagen. This cycle of activity is indistinguishable from the natural cycle [34]. This animal model had been successfully utilized in the analysis of hair-loss management [35, 36].

HuMSCs have been widely analyzed in the stem-cell therapy domain owing to their high self-renewal ability, differentiation ability, immune regulation, paracrine effects, anti-fibrotic activity, anti-inflammatory effect, and low ethical controversy [37]. MSCs repair damaged tissues and promote tissue regeneration largely through the paracrine function [38]. Based on the paracrine role of MSCs, several studies have investigated CM as an alternative therapy [39]. Local supplementation of growth factors and cytokines was conducive to hair growth [40]. Growth factors and cytokines extracted from ADSCs, such as VEGF, b-FGF, PDGF, and KGF, positively promote the proliferation of dermal papilla cells and hair growth [40]. Therefore, we speculate that growth factors and cytokines in GS-HuMSCs-CM may be an effective treatment for alopecia. VEGF is involved in the formation of new blood vessels during anagen and stimulates the growth of hair follicles and hair shafts [41]. IGF-1 exerts a crucial role in the regulation of cell differentiation and tissue regeneration during hair follicle development [42]. KGF is an effective cell-protective growth factor that prevents hair follicle apoptosis through the denovo synthesis of proteins [43]. HGF contributes to anagen maintenance by retarding hair follicle regression [44].

Optimizing stem cell culture conditions to up-regulate key growth factors/cytokines for regeneration therapy is a significant strategy. The cultivation of MSCs in 3D scaffolds or in a hypoxic condition can upregulate the paracrine activity of MSCs [26, 27]. Herein, the CM of HuMSCs at 100% confluence, HuMSCs-CM Day 3 after confluency, and GS-HuMSCs-CM (Day 3) were collected. ELISA analysis revealed that VEGF, IGF-1, KGF and HGF were significantly up-regulated in GS-HuMSCs-CM (*P < 0.05) (Fig. 3). As was previously demonstrated, the gelatin sponge provides the cells with a three-dimensional scaffold that is more consistent with the environment in vivo and helps maintain optimal cell survival and secretion efficacy [29]. As a commonly utilized clinical material, gelatin sponge is cheap and easy to obtain and can be used as a cell scaffold for more optimal clinical translation.

The hair follicle cycle consists of three phases: anagen, catagen, and telogen [45]. Hair regeneration can be promoted by prolonging the anagen period, shortening the telogen period, or facilitating the telogen–anagen transition [46]. Growth factors and cytokines, such as from the ADSC-CM, could promote hair growth by inducing the hair cycle’s anagen phase [40]. To induce a synchronized hair cycle, the hairs of dorsal skin were to be depilated [30]. The depilated skin of mice was pink during telogen and darkened at the initiation of anagen. Physical and chemical depilation may induce the C57BL/6J mouse strain to enter anagen; therefore, the time of skin color changes in the mice’s depilation area can be regarded as the hair-follicle time from telogen to anagen. The experimental results indicated that compared with the control group, GS-HuMSCs-CM and HuMSCs could significantly shorten the time of skin color changes and that of hair growth. The histomorphometric analysis indicated that on day 7 after injection, most of the hair follicles were in Anagen in the GS-HuMSCs-CM group and HuMSCs group, and that in the control group, they were still in Telogen. On day 21, hair follicles in the GS-HuMSCs-CM group entered catagen II, and the hair follicles in HuMSCs group entered catagen VI, whereas the hair follicles in the control group entered catagen VIII. The results indicated that GS-HuMSCs-CM and HuMSCs could induce the hair follicles to enter the anagen stage earlier and maintain hair growth for a longer time. The effect of the GS-HuMSCs-CM group was more significant than that of the HuMSCs group.

We found that after days 14 and 21 of the last injection, the hair length in the GS-HuMSCs-CM group and HuMSCs group were longer than that in the control group (P < 0.05) and that the hair weight in the GS-HuMSCs-CM group was significantly heavier than that in the control group (P < 0.01). However, no significant difference in hair weight was found between the HuMSCs group and the control group on day 21 (P > 0.05). The hair diameter in the GS-HuMSCs-CM group and HuMSCs group were thicker than in the control group (P < 0.01). GS-HuMSCs-CM and HuMSCs have a positive effect on hair growth by elongating the hair shaft and increasing the hair diameter. NS injection also induced the hair growth cycle from telogen to anagen, which might have occurred through the needle mechanical stimulation.

Hair growth requires adequate nutrition, oxygen, and sufficient blood supply. Angiogenesis around hair follicles is associated with hair cycles [47]. Hair growth is usually accompanied by increased angiogenesis [48]. VEGF is also an effective angiogenic agent for promoting hair growth and increasing the size and number of hair follicles. The effect of growth factors on hair growth is related to the stimulation of angiogenesis [35, 49]. We noted significant dilation of the blood vessels and the increased connections between different blood vessel plexus on the back skin in GS-HuMSCs-CM treated mice. Angiogenesis induced by GS-HuMSCs-CM might also contribute to the anagen phase induction and hair growth.


In conclusion, GS-HuMSCs-CM promoted hair growth, potentially by inducing and prolongating the anagen phase, and by enhancing skin angiogenesis in the mice model. GS-HuMSCs-CM presented more optimal results than in HuMSCs in promoting hair growth.

Future perspective

Hair regeneration techniques include the subcutaneous injection of platelet concentrate, stem cells, and conditioned medium. Local injection of concentrated platelet products can provide nutrients for hair, which can promote the telogen period of hair to re-enter the anagen period. The application of stem-cell-related technology to treatment is a prominent research topic in the medical field. Stem cells exhibit unique and powerful differentiation, immunomodulatory, and anti-inflammatory capabilities. Conditioned mediums of MSCs contain a variety of growth factors that can enhance scalp blood supply and hair follicle cycle, exert multiple effects on hair-loss treatment, and have unlimited potential in promoting hair growth and regeneration. The conditioned mediums can avoid some of the risks associated with stem cells. Meanwhile, the conditioned mediums can be prepared into freeze-dried powder, which exhibits certain advantages in use, storage, and transportation, and is a potentially novel treatment method. There are more components in the conditioned medium of HuMSCs. We can determine which protein substances promote hair growth and the expression of related markers in the cell-signaling pathway. Currently, isolated hair follicles during hair transplant surgery are temporarily stored in lactate Ringer's solution at 4 ℃. We can analyze the activity and survival of the isolated hair follicles stored in the conditioned medium of HuMSCs with lactate Ringer's solution and normal saline.

Availability of data and materials

Not applicable.


  1. Ruchy J, De-Eknamkul W. Potential targets in the discovery of new hair growth promoters for androgenic alopecia. Expert Opin Ther Targets. 2014;18:787–806.

    Article  Google Scholar 

  2. Sawant N, Chikhalkar S, Mehta V, et al. Androgenetic alopecia: quality of life and associated lifestyle patterns. Int J Trichology. 2010;2(2):81–5.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Karoline K, Kersti F. Biology of the hair follicle: the basics. Semin Cutan Med Surg. 2006;25:2–10.

    Article  Google Scholar 

  4. Yanna K, Aline B, Antonella T. Androgenetic alopecia: an update of treatment options. Drugs. 2016;76:1349–64.

    Article  Google Scholar 

  5. Yusuke S, Edward Hosea N, Hiroshi S, et al. Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature. Regen Ther. 2022;21:527–39.

    Article  Google Scholar 

  6. Hirotaro F, Hirotaka S. Hair regeneration treatment using adipose-derived stem cell conditioned medium: follow-up with trichograms. Eplasty. 2015;15: e10.

    Google Scholar 

  7. Arkaitz M, Eva H, Enrique M, et al. Influence of mesenchymal stem cell sources on their regenerative capacities on different surfaces. Cells. 2021.

    Article  Google Scholar 

  8. Prockop Darwin J, Malcolm B, Fibbe Willem E, et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy. 2010;12:576–8.

    Article  CAS  PubMed  Google Scholar 

  9. Murphy Matthew B, Kathryn M, Caplan Arnold I. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013;45: e54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Vincenzo M, Simona DM. Dental pulp stem cells (DPSCs) and tissue regeneration: mechanisms mediated by direct, paracrine, or autocrine effects. Biomedicines. 2023.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Rui L, Li Y, Xiaoyan D. Preconditioning mesenchymal stromal cells with flagellin enhances the anti-inflammatory ability of their secretome against lipopolysaccharide-induced acute lung injury. Mol Med Rep. 2020;22:2753–66.

    Google Scholar 

  12. Danpeng S, Hongwei W, Hongyan Z, et al. Pre-clinical efficacy evaluation of human umbilical cord mesenchymal stem cells for ischemic stroke. Front Immunol. 2022;13:1095469.

    Google Scholar 

  13. Zineng Y, Han Y, Jiang, W, et al. Engineering exosomes by three-dimensional porous scaffold culture of human umbilical cord mesenchymal stem cells promote osteochondral repair. Mater Today Bio. 2023;19:100549.

    Article  Google Scholar 

  14. Xiaoting L, Jing L, Mimi L, et al. Intravenously administered human umbilical cord-derived mesenchymal stem cell (hucmsc) improves cardiac performance following infarction via immune modulation. Stem Cells Int. 2023;2023:6256115.

    Google Scholar 

  15. Huanjie C, Yulong L, Yiping Z, et al. Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats. Front Pharmacol. 2022;13:1070736.

    Google Scholar 

  16. Lian Xiao-Fen L, Hong-Li L, Dong-Hui L, et al. Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus. World J Diabetes. 2022;13:877–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Gui M, Chen E. Current concerns and considerations regarding mesenchymal stem cells therapy in perplexing severe liver diseases. Zhonghua Gan Zang Bing Za Zhi. 2021;29:591–4.

    CAS  PubMed  Google Scholar 

  18. Yang Chao W, Mingjun YM, et al. The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases. Stem Cell Res Ther. 2021;12:103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Aliai L, Barbara M, Jole M, et al. Heterologous wharton’s jelly derived mesenchymal stem cells application on a large chronic skin wound in a 6-month-old filly. Front Vet Sci. 2019;6:9.

    Article  Google Scholar 

  20. Miryam M, Camille A, Jérôme L, et al. Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products. Stem Cell Res Ther. 2021;12:152.

    Article  Google Scholar 

  21. Jinyan W, Quyang Y, Sainan, W, et al. Adipose-derived stem cell exosomes promoted hair regeneration. Tissue Eng Regen Med. 2021;18:685–91.

    Article  Google Scholar 

  22. Bo-Young Y, Youn-Ho S, Hee-Hoon Y, et al. Application of mesenchymal stem cells derived from bone marrow and umbilical cord in human hair multiplication. J Dermatol Sci. 2010;60:74–83.

    Article  Google Scholar 

  23. Tarini Nawamalie Abeysinghe G, Zeinab M, Tariqur RM, et al. Dental derived stem cell conditioned media for hair growth stimulation. PLoS One. 2019;14: e0216003.

    Article  Google Scholar 

  24. Hirotaro F, Keigo N, Hirotaka S. Hair regeneration therapy: application of adipose-derived stem cells. Curr Stem Cell Res Ther. 2017;12:531–4.

    Google Scholar 

  25. Sushmitha S, Antara B, Rosa DL, et al. Concise review on clinical applications of conditioned medium derived from human umbilical cord-mesenchymal stem cells (UC-MSCs). Int J Hematol Oncol Stem Cell Res. 2018;12:230–4.

    Google Scholar 

  26. Lujun Y, Jie M, Saiyang G, et al. Platelet poor plasma gel combined with amnion improves the therapeutic effects of human umbilical cord-derived mesenchymal stem cells on wound healing in rats. Mol Med Rep. 2017;16:3494–502.

    Article  Google Scholar 

  27. Byung-Soon P, Won-Serk K, Joon-Seok C, et al. Hair growth stimulated by conditioned medium of adipose-derived stem cells is enhanced by hypoxia: evidence of increased growth factor secretion. Biomed Res. 2010;31:27–34.

    Article  Google Scholar 

  28. Yun-Mi J, YoungKwan S, Wang-Kyun K, et al. Ultraviolet B preconditioning enhances the hair growth-promoting effects of adipose-derived stem cells via generation of reactive oxygen species. Stem Cells Dev. 2013;22:158–68.

    Article  Google Scholar 

  29. Danyan Y, Bingna Z, Sixun W, et al. Characteristics and clinical potential of a cellularly modified gelatin sponge. J Appl Biomater Funct Mater. 2021;19:22808000211035060.

    Google Scholar 

  30. Martin M, Tianhua H, Lujun Y, et al. Human umbilical cord wharton jelly cells promote extra-pancreatic insulin formation and repair of renal damage in STZ-induced diabetic mice. Cell Commun Signal. 2017;15:43.

    Article  Google Scholar 

  31. Vijaya V, James O, Milan U, et al. Vitamin D3 analogs stimulate hair growth in nude mice. Endocrinology. 2002;143:4389–96.

    Article  Google Scholar 

  32. Müller-Röver S, Handjiski B, van der Veen C, et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol. 2001;117:3–15.

    Article  PubMed  Google Scholar 

  33. Slominski A, Paus R. Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol. 1993;101:90S-97S.

    Article  CAS  PubMed  Google Scholar 

  34. Paus R, Handjiski B, Czarnetzki BM, et al. A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J Invest Dermatol. 1994;103:143–7.

    Article  CAS  PubMed  Google Scholar 

  35. Min Kyung J, Soogyeong H, Scarlett Yoona H, et al. Hair-growth stimulation by conditioned medium from vitamin D3-activated preadipocytes in C57BL/6 mice. Life Sci. 2015;128:39–46.

    Article  Google Scholar 

  36. Ramya Lakshmi R, Prakash G, Soon Sun B, et al. Extracellular vesicles derived from MSCs activates dermal papilla cell in vitro and promotes hair follicle conversion from telogen to anagen in mice. Sci Rep. 2017;7:15560.

    Article  Google Scholar 

  37. Qixin X, Rui L, Jia J, et al. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? Stem Cell Res Ther. 2020;11:519.

    Article  Google Scholar 

  38. Baraniak Priya R, McDevitt Todd C. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010;5:121–43.

    Article  CAS  PubMed  Google Scholar 

  39. Sushilkumar R, ShashiKant T. Human mesenchymal stem cell-derived conditioned media for hair regeneration applications. J Stem Cells. 2016;11:201–11.

    Google Scholar 

  40. Shune X, Yurong D, Xiaojin M, et al. Promotion of hair growth by conditioned medium from extracellular matrix/stromal vascular fraction gel in C57BL/6 mice. Stem Cells Int. 2020;2020:9054514.

    Google Scholar 

  41. Makoto O, Yasuhiko T. Promoted growth of murine hair follicles through controlled release of vascular endothelial growth factor. Biomaterials. 2002;23:2367–73.

    Article  Google Scholar 

  42. DongHo B, MiJi C, SoonRe K, et al. Human umbilical cord blood mesenchymal stem cells engineered to overexpress growth factors accelerate outcomes in hair growth. Korean J Physiol Pharmacol. 2018;22:555–66.

    Article  Google Scholar 

  43. Susanne B, Monika K, Enikö B, et al. Keratinocyte growth factor protects epidermis and hair follicles from cell death induced by UV irradiation, chemotherapeutic or cytotoxic agents. J Cell Sci. 2006;119:4841–9.

    Article  Google Scholar 

  44. Yonghao Q, Miao L, Lian, X, et al. Therapeutic role of human hepatocyte growth factor (HGF) in treating hair loss. PeerJ. 2016;4: e2624.

    Article  Google Scholar 

  45. Laura A, Elaine F. The hair cycle. J Cell Sci. 2006;119:391–3.

    Article  Google Scholar 

  46. Mira C, Soon-Jin C, Sunhyae J, et al. Shikimic acid, a mannose bioisostere, promotes hair growth with the induction of anagen hair cycle. Sci Rep. 2019;9:17008.

    Article  Google Scholar 

  47. Hanxiao C, Jufang Z, Jinsheng L, et al. Platelet-rich plasma stimulates angiogenesis in mice which may promote hair growth. Eur J Med Res. 2017;22:39.

    Article  Google Scholar 

  48. Mecklenburg L, Tobin DJ, Müller-Röver S, et al. Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol. 2000;114:909–16.

    Article  CAS  PubMed  Google Scholar 

  49. Hyun WC, Gyeong-Hun P, Xunwei, W, et al. The basic mechanism of hair growth stimulation by adipose-derived stem cells and their secretory factors. Curr Stem Cell Res Ther. 2017;12:535–43.

    Google Scholar 

Download references




This study was supported by Shantou Medical Science and Technology Planning Project, 2022-169-66.

Author information

Authors and Affiliations



JN and LY participated in the design of this study. They collected, processed and analyzed the experimental data. After analyzing and sorting out the data, JN made figure, and drafted of manuscript. DY was responsible for cell culture, together with WZ and SM collected experimental data and important background information. ZW and YK were nursed the mice and assisted with animal experiment. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Lujun Yang.

Ethics declarations

Ethics approval and content to participate.

The study protocol was approved by the institutional ethics committee of animal research under the Law of Animal Research and Statutory Regulations in China. All animal experiments were approved by the Institutional Animal Care and Use Committee of the Shantou University Medical College.

Competing interests

All authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ni, J., Ye, D., Zeng, W. et al. Promotion of hair growth by a conditioned medium from human umbilical cord mesenchymal stem cells cultivated in a 3D scaffold of gelatin sponge. Eur J Med Res 29, 270 (2024).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: